Frontlight ResearchEarly access
Duchenne muscular dystrophy trials in Sweden
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
- Where
- Solna
- Age
- 9 years to 17 years
- People
- 138 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT05933057 · EU 2023-503521-19-00 - No phaseEnrolling by invitationCan External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?
- Where
- Stockholm
- Age
- 5 years to 17 years
- People
- 20
- Run by
- taVNS AB
See details and how to joinNCT07543302